[article]
| Titre : |
FOXP1 syndrome: a review of the literature and practice parameters for medical assessment and monitoring |
| Type de document : |
texte imprimé |
| Auteurs : |
Reymundo LOZANO, Auteur ; Catherine GBEKIE, Auteur ; Paige M. SIPER, Auteur ; Shubhika SRIVASTAVA, Auteur ; Jeffrey M. SALAND, Auteur ; Swathi SETHURAM, Auteur ; Lara TANG, Auteur ; Elodie DRAPEAU, Auteur ; Yitzchak FRANK, Auteur ; Joseph D. BUXBAUM, Auteur ; Alexander KOLEVZON, Auteur |
| Langues : |
Anglais (eng) |
| Mots-clés : |
Autism Spectrum Disorder Forkhead Transcription Factors Humans In Situ Hybridization, Fluorescence Intellectual Disability Repressor Proteins Asd Autism spectrum disorder Foxp1 FOXP1 syndrome Forkhead box protein 1 Acadia, Ritrova, and Alkermes. The authors declare no competing interests. |
| Index. décimale : |
PER Périodiques |
| Résumé : |
FOXP1 syndrome is a neurodevelopmental disorder caused by mutations or deletions that disrupt the forkhead box protein 1 (FOXP1) gene, which encodes a transcription factor important for the early development of many organ systems, including the brain. Numerous clinical studies have elucidated the role of FOXP1 in neurodevelopment and have characterized a phenotype. FOXP1 syndrome is associated with intellectual disability, language deficits, autism spectrum disorder, hypotonia, and congenital anomalies, including mild dysmorphic features, and brain, cardiac, and urogenital abnormalities. Here, we present a review of human studies summarizing the clinical features of individuals with FOXP1 syndrome and enlist a multidisciplinary group of clinicians (pediatrics, genetics, psychiatry, neurology, cardiology, endocrinology, nephrology, and psychology) to provide recommendations for the assessment of FOXP1 syndrome. |
| En ligne : |
https://dx.doi.org/10.1186/s11689-021-09358-1 |
| Permalink : |
https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=574 |
in Journal of Neurodevelopmental Disorders > 13 (2021)
[article] FOXP1 syndrome: a review of the literature and practice parameters for medical assessment and monitoring [texte imprimé] / Reymundo LOZANO, Auteur ; Catherine GBEKIE, Auteur ; Paige M. SIPER, Auteur ; Shubhika SRIVASTAVA, Auteur ; Jeffrey M. SALAND, Auteur ; Swathi SETHURAM, Auteur ; Lara TANG, Auteur ; Elodie DRAPEAU, Auteur ; Yitzchak FRANK, Auteur ; Joseph D. BUXBAUM, Auteur ; Alexander KOLEVZON, Auteur. Langues : Anglais ( eng) in Journal of Neurodevelopmental Disorders > 13 (2021)
| Mots-clés : |
Autism Spectrum Disorder Forkhead Transcription Factors Humans In Situ Hybridization, Fluorescence Intellectual Disability Repressor Proteins Asd Autism spectrum disorder Foxp1 FOXP1 syndrome Forkhead box protein 1 Acadia, Ritrova, and Alkermes. The authors declare no competing interests. |
| Index. décimale : |
PER Périodiques |
| Résumé : |
FOXP1 syndrome is a neurodevelopmental disorder caused by mutations or deletions that disrupt the forkhead box protein 1 (FOXP1) gene, which encodes a transcription factor important for the early development of many organ systems, including the brain. Numerous clinical studies have elucidated the role of FOXP1 in neurodevelopment and have characterized a phenotype. FOXP1 syndrome is associated with intellectual disability, language deficits, autism spectrum disorder, hypotonia, and congenital anomalies, including mild dysmorphic features, and brain, cardiac, and urogenital abnormalities. Here, we present a review of human studies summarizing the clinical features of individuals with FOXP1 syndrome and enlist a multidisciplinary group of clinicians (pediatrics, genetics, psychiatry, neurology, cardiology, endocrinology, nephrology, and psychology) to provide recommendations for the assessment of FOXP1 syndrome. |
| En ligne : |
https://dx.doi.org/10.1186/s11689-021-09358-1 |
| Permalink : |
https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=574 |
|  |